Pivotal Bio Venture Partners Investment Advisor LLC Portfolio Holdings

Pivotal Bio Venture Partners Investment Advisor LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $106 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $42.4M, Arcutis Biotherapeutics, Inc. with a value of $29.7M, Inozyme Pharma, Inc. with a value of $18M, Trevi Therapeutics, Inc. with a value of $6.27M, and Vigil Neuroscience, Inc. with a value of $4.46M.

Examining the 13F form we can see an increase of $34.4M in the current position value, from $71.5M to 106M.

Pivotal Bio Venture Partners Investment Advisor LLC is based out at San Francisco, CA

Below you can find more details about Pivotal Bio Venture Partners Investment Advisor LLC portfolio as well as his latest detailed transactions.